Gen plizyè fason pou trete kansè kolon, selon etap ak gravite maladi a.
Kèk tretman komen yo enkli:
1. Operasyon: Se tretman ki pi komen pou kansè kolon.
Chirijyen an retire pati kansè nan kolon an ak ganglionn lenfatik ki toupre yo.
Nan kèk ka, yo ka retire yon ti pati nan kolon ki an sante sou chak bò kansè a.
2. Chimyoterapi: Tretman sa a itilize medikaman pou touye selil kansè yo.
Li ka bay anvan oswa apre operasyon, oswa nan konbinezon ak terapi radyasyon.
3. Terapi radyasyon: Tretman sa a itilize radyasyon ki gen anpil enèji pou touye selil kansè yo.
Li kapab itilize anvan oswa apre operasyon, oswa nan konbinezon ak chimyoterapi.
4. Terapi vize: Tretman sa a itilize medikaman ki vize molekil espesifik ki patisipe nan kwasans ak pwopagasyon selil kansè yo.
Li souvan itilize nan konbinezon ak chimyoterapi.
5. Immunotherapy: Tretman sa a ede sistèm iminitè a rekonèt ak atake selil kansè yo.
Li souvan itilize nan konbinezon ak lòt tretman.
6. Swen palyatif: Kalite swen sa a konsantre sou soulaje sentòm yo ak amelyore kalite lavi pou pasyan ki gen kansè kolon avanse.
Li ka gen ladan l tretman doulè, sipò nitrisyonèl ak sipò emosyonèl.
Li enpòtan pou diskite sou pi bon opsyon tretman yo avèk yon pwofesyonèl swen sante, paske apwòch ki pi efikas la pral depann de sitiyasyon espesifik endividyèl la.
Tu Z, Ma Y, Akers W, Achilefu S, Gu Y: Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy. J Cancer Res Clin Oncol. 2014, 140 (4): 623-32.
Kim YE, Kwon S, Wu G, Kim D, Park BK, Park JA, Choi KC, Kim DS, Kwon HJ, Lee Y: Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model. Oncotarget. 2014, 5 (18): 8402-15.
Khan FA, Albalawi R, Pottoo FH: Trends in targeted delivery of nanomaterials in colon cancer diagnosis and treatment. Med Res Rev. 2022, 42 (1): 227-258.
Kwon S, Kim YE, Park JA, Kim DS, Kwon HJ, Lee Y: Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model. BMB Rep. 2014, 47 (4): 215-20.
Viale PH: Expanded treatment options in the adjuvant therapy of colon cancer: implications for oncology nurses. Oncol Nurs Forum. 2006, 33 (1): 81-90.
Ortiz R, Prados J, Melguizo C, Rama AR, Alvarez PJ, Rodríguez-Serrano F, Caba O, Boulaiz H, Aranega A: Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells. Biomed Pharmacother. 2012, 66 (7): 563-7.
['Avètisman: medikal']
['Sit entènèt sa a se pou rezon edikasyonèl ak enfòmasyon sèlman e li pa bay konsèy medikal oswa sèvis pwofesyonèl.']
['Enfòmasyon yo bay la pa dwe itilize pou fè dyagnostik oswa trete yon pwoblèm sante oswa maladi, e moun k ap chèche konsèy medikal pèsonèl ta dwe konsilte yon doktè ki gen lisans.']
['Tanpri note ke rezo neural ki jenere repons pou kesyon yo, pa egzat sitou lè li rive pou kontni nimerik. pa egzanp, kantite moun ki te dyagnostike ak yon maladi espesifik.']
['Toujou chèche konsèy doktè ou oswa lòt founisè sante ki kalifye konsènan yon kondisyon medikal. Pa janm meprize konsèy medikal pwofesyonèl oswa reta nan chèche li paske nan yon bagay ou te li sou sit entènèt sa a. Si ou panse ou ka gen yon ijans medikal, rele 911 oswa ale nan sal ijans ki pi pre a imedyatman. Pa gen okenn relasyon doktè-pasyan ki kreye pa sit entènèt sa a oswa itilizasyon li yo. Ni BioMedLib ni anplwaye li yo, ni okenn kontribitè nan sit entènèt sa a, fè okenn reprezantasyon, eksprime oswa enplisit, ki gen rapò ak enfòmasyon yo bay isit la oswa pou itilize li yo.']
['Avètisman: dwa otè']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) bay rekou pou mèt copyright ki kwè ke materyèl ki parèt sou entènèt la vyole dwa yo anba lwa copyright Etazini. ']
['Si ou kwè ak tout konfyans ke nenpòt kontni oswa materyèl ki disponib an koneksyon avèk sit entènèt nou an oswa sèvis vyole copyright ou, ou (oswa ajan ou) ka voye nou yon avi pou mande pou retire kontni an oswa materyèl la, oswa aksè a li bloke.']
['Anons yo dwe voye alekri pa imel (gade seksyon "Kontak" pou adrès imel)']
['DMCA mande pou avi ou sou vyolasyon dwa otè a genyen enfòmasyon sa yo: (1) deskripsyon travay ki gen dwa otè a ki sijè vyolasyon an; (2) deskripsyon kontni ki vyole dwa otè a ak enfòmasyon ki sifi pou pèmèt nou jwenn kontni an; (3) enfòmasyon pou kontakte ou, ki gen ladan adrès ou, nimewo telefòn ou ak adrès imel ou; (4) yon deklarasyon ou fè ki di ou gen bon lafwa ke kontni an nan fason ou pote plent la pa otorize pa mèt pwopriyete dwa otè a, oswa ajan li, oswa pa operasyon nenpòt lwa; ']
['(5) yon deklarasyon ou siyen sou penalite fo temwayaj ke enfòmasyon ki nan notifikasyon an egzat e ke ou gen otorite pou fè respekte dwa otè yo ke yo reklame ke yo vyole yo;']
['e (6) yon siyati fizik oubyen elektwonik mèt copyright la oubyen yon moun ki otorize pou aji sou non mèt copyright la. ']
['Si ou pa bay tout enfòmasyon ki anwo yo, sa ka fè ke nou pa trete plent ou a byen vit.']
['Kontak']
['Tanpri voye nou yon imèl avèk nenpòt kesyon / sijesyon.']
How to treat colon cancer?
There are several ways to treat colon cancer, depending on the stage and severity of the disease.
Some common treatments include:
1. Surgery: This is the most common treatment for colon cancer.
The surgeon removes the cancerous part of the colon and nearby lymph nodes.
In some cases, a small part of the healthy colon on either side of the cancer may also be removed.
2. Chemotherapy: This treatment uses drugs to kill cancer cells.
It can be given before or after surgery, or in combination with radiation therapy.
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be used before or after surgery, or in combination with chemotherapy.
4. Targeted therapy: This treatment uses drugs that target specific molecules involved in the growth and spread of cancer cells.
It is often used in combination with chemotherapy.
5. Immunotherapy: This treatment helps the immune system to recognize and attack cancer cells.
It is often used in combination with other treatments.
6. Palliative care: This type of care focuses on relieving symptoms and improving the quality of life for patients with advanced colon cancer.
It may include pain management, nutritional support, and emotional support.
It is important to discuss the best treatment options with a healthcare professional, as the most effective approach will depend on the individual's specific situation.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['sou']
['BioMedLib itilize òdinatè otomatik (algoritm aprantisaj machin) pou jenere pè kesyon ak repons.']
['Nou kòmanse ak 35 milyon piblikasyon biomedik de PubMed/Medline. tou, paj entènèt de RefinedWeb.']
